seed
Stage
1
Investors
About
Leash Bio builds a proprietary, large-scale dataset of protein–molecule interactions by screening millions of compounds against hundreds of protein targets (claiming tens of billions of measurements) and uses those data to train machine learning models to design and test novel molecules for drug discovery.
Explore Leash Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.